Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses (Q40802250)

23 September 2017

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses (English)

1 reference

23 September 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Judith R Kroep

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sjoerd H van der Burg

16

object named as

Sjoerd H van der Burg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

14

Jacobus Burggraaf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Marij J Welters

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Hélène van Meir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Nikki M Loof

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Vanessa J van Ham

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Suzanne van Duikeren

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Saskia J Santegoets

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Ramon Arens

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Marieke L de Kam

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Adam F Cohen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Mariette I van Poelgeest

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Gemma G Kenter

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Cornelis J Melief

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

1 April 2016

1 reference

Science Translational Medicine

23 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

334ra52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Therapeutic vaccination against human papilloma virus induced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Carboplatin: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Preclinical antitumor and toxicologic profile of carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Indirect-response model for the time course of leukopenia with anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Multiple-pool cell lifespan model of hematologic effects of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAD8307

10.1126/SCITRANSLMED.AAD8307

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27075626%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference